Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: A systematic review and meta-analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Huang, Yi ^a   Yu, Xi ^b   Wang, Lingyan ^c   Zhou, Shengjun ^a   Sun, Jie ^a   Feng, Nan ^a   Nie, Sheng ^a   Wu, Jingmi ^a   Gao, Feng ^a   Fei, Bing ^a   Wang, Jianyong ^a   Lin, Zhiqing ^a   Li, Xianru ^a   Xu, Leiting ^d   Gao, Xiang ^a   Ye, Meng ^d   Duan, Shiwei ^d  

^a NINGBO FIRST HOSPITAL   (China)

^b Lihuili Hospital   (China)

^c NINGBO NO 2 HOSPITAL   (China)

^d NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN;

ADENOCARCINOMA; ARTICLE; CANCER RISK; CASE CONTROL STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HEMATOLOGIC MALIGNANCY; HUMAN; LTA GENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER;

ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LYMPHOTOXIN-ALPHA; NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK;

EID: 84892571005     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082519     Document Type: Article

References (66)

1. Kimman M, Norman R, Jan S, Kingston D, Woodward M (2012) The burden of cancer in member countries of the Association of Southeast Asian Nations (ASEAN). Asian Pac J Cancer Prev 13: 411-420. doi:10.7314/APJCP.2012.13.2.411. PubMed: 22524799.
2. Barzan D, Veldwijk MR, Herskind C, Li Y, Zhang B et al. (2013) Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations. Eur J Hum Genet 21: 1286-1292. PubMed: 23486537.
3. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860-867. doi:10.1038/nature01322. PubMed: 12490959.
4. Feller L, Altini M, Lemmer J (2013) Inflammation in the context of oral cancer. Oral Oncol 49: 887-892. doi:10.1016/j.oraloncology.2013.07.003. PubMed: 23910564.
5. Akhurst RJ, Hata A (2012) Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov 11: 790-811. doi:10.1038/nrd3810. PubMed: 23000686.
6. Wang K, Grivennikov SI, Karin M (2013) Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases. Ann Rheum Dis 72 (Suppl 2): ii100-ii103. PubMed: 23253923.
7. Morishige T, Yoshioka Y, Narimatsu S, Ikemizu S, Tsunoda S et al. (2013) Mutants of lymphotoxin-alpha with augmented cytotoxic activity via TNFR1 for use in cancer therapy. Cytokine 61: 578-584. doi:10.1016/j.cyto.2012.11.005. PubMed: 23246116.
8. Allensworth JL, Sauer SJ, Lyerly HK, Morse MA, Devi GR (2013) Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-alpha-independent mechanism. Breast Cancer Res Treat 137: 359-371. doi:10.1007/s10549-012-2352-6. PubMed: 23225169.
9. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3: 745-756. doi:10.1038/nri1184. PubMed: 12949498.
10. Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B et al. (1987) Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 165: 1581-1594. doi:10.1084/jem.165.6.1581. PubMed: 3108447.
11. Cope AP (1998) Regulation of autoimmunity by proinflammatory cytokines. Curr Opin Immunol 10: 669-676. doi:10.1016/S0952-7915(98)80087-3. PubMed: 9914219.
12. Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10: 411-452. doi:10.1146/annurev.iy.10.040192.002211. PubMed: 1590993.
13. Carroll MC, Katzman P, Alicot EM, Koller BH, Geraghty DE et al. (1987) Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A 84: 8535-8539. doi:10.1073/pnas.84.23.8535. PubMed: 2825194.
14. Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE et al. (2009) Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9: 134-142. doi:10.1038/nrc2587. PubMed: 19148183.
15. Lu R, Dou X, Gao X, Zhang J, Ni J et al. (2012) A functional polymorphism of lymphotoxin-alpha (LTA) gene rs909253 is associated with gastric cancer risk in an Asian population. Cancer Epidemiol 36: e380-e386. doi:10.1016/j.canep. 2012.05.014. PubMed: 22748850.
16. Zhang Y, Wang MY, He J, Wang JC, Yang YJ et al. (2012) Tumor necrosis factor-alpha induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study. PLOS ONE 7: e37846. doi:10.1371/journal.pone.0037846. PubMed: 22666399.
17. Zhou P, Huang W, Chu X, Du LF, Li JP et al. (2012) The lymphotoxin-alpha 252AG polymorphism and breast cancer: a meta-analysis. Asian Pac J Cancer Prev 13: 1949-1952. doi:10.7314/APJCP.2012.13.5.1949. PubMed: 22901152.
18. Sainz J, Rudolph A, Hoffmeister M, Frank B, Brenner H et al. (2012) Effect of type 2 diabetes predisposing genetic variants on colorectal cancer risk. J Clin Endocrinol Metab 97: E845-E851. doi:10.1210/jc.2011-2565. PubMed: 22419714.
19. Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I et al. (2009) Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLOS ONE 4: e5360. doi:10.1371/journal.pone.0005360. PubMed: 19390683.
20. Aissani B, Ogwaro KM, Shrestha S, Tang J, Breen EC et al. (2009) The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma. J Acquir Immune Defic Syndr 52: 170-179. doi:10.1097/QAI.0b013e3181b017d5. PubMed: 19654554.
21. Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S et al. (2010) Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 171: 267-276. doi:10.1093/aje/kwp383. PubMed: 20047977.
22. García-González MA, Nicolás-Pérez D, Lanas A, Bujanda L, Carrera P et al. (2012) Prognostic role of host cyclooxygenase and cytokine genotypes in a Caucasian cohort of patients with gastric adenocarcinoma. PLOS ONE 7: e46179. doi:10.1371/journal.pone.0046179. PubMed: 23029430.
23. Rausch SM, Gonzalez BD, Clark MM, Patten C, Felten S et al. (2012) SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors. Lung Cancer 77: 217-223. doi:10.1016/j.lungcan.2012.02.017. PubMed: 22464751.
24. Nieves-Ramirez ME, Partida-Rodriguez O, Alegre-Crespo PE, Tapia-Lugo Mdel C, Perez-Rodriguez ME (2011) Characterization of Single-Nucleotide Polymorphisms in the Tumor Necrosis Factor alpha Promoter Region and in Lymphotoxin alpha in Squamous Intraepithelial Lesions, Precursors of Cervical Cancer. Transl Oncol 4: 336-344.
25. Messer G, Spengler U, Jung MC, Honold G, Blömer K et al. (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173: 209-219. doi:10.1084/jem.173.1.209. PubMed: 1670638.
26. Tan JH, Temple SE, Kee C, Waterer GW, Tan CR et al. (2011) Characterisation of TNF block haplotypes affecting the production of TNF and LTA. Tissue Antigens 77: 100-106. doi:10.1111/j.1399-0039.2010.01582.x. PubMed: 21214521.
27. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R et al. (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32: 650-654. doi:10.1038/ng1047. PubMed: 12426569.
28. Knight JC, Keating BJ, Kwiatkowski DP (2004) Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. Nat Genet 36: 394-399. doi:10.1038/ng1331. PubMed: 15052269.
29. Boraska V, Rayner NW, Groves CJ, Frayling TM, Diakite M et al. (2010) Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes. BMC Med Genet 11: 69. doi:10.1186/1471-2350-11-69. PubMed: 20459604.
30. Belfer I, Buzas B, Hipp H, Dean M, Evans C et al. (2004) Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans. Genes Immun 5: 505-512. doi:10.1038/sj.gene. 6364118. PubMed: 15306845.
31. Takei K, Ikeda S, Arai T, Tanaka N, Muramatsu M et al. (2008) Lymphotoxin-alpha polymorphisms and presence of cancer in 1,536 consecutive autopsy cases. BMC Cancer 8: 235. doi:10.1186/1471-2407-8-235. PubMed: 18700950.
32. Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA et al. (2007) Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 121: 483-490. doi:10.1007/s00439-006-0315-x. PubMed: 17216494.
33. Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W et al. (2006) Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 66: 9771-9780. doi:10.1158/0008-5472.CAN- 06-0324. PubMed: 17018637.
34. Lee SG, Kim B, Yook JH, Oh ST, Lee I et al. (2004) TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population. Cytokine 28: 75-82. doi:10.1016/j.cyto.2004.06.009. PubMed: 15381184.
35. Niwa Y, Hirose K, Matsuo K, Tajima K, Ikoma Y et al. (2005) Lymphotoxin-alpha polymorphism and the risk of cervical cancer in Japanese subjects. Cancer Lett 218: 63-68. doi:10.1016/j.canlet.2004.09.021. PubMed: 15639341.
36. Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS et al. (2006) Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 107: 4101-4108. doi:10.1182/blood-2005-10-4160. PubMed: 16449530.
37. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R et al. (2006) Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15: 1126-1131. doi:10.1158/1055-9965.EPI-06-0042. PubMed: 16775170.
38. Liu X, Plummer SJ, Nock NL, Casey G, Witte JS (2006) Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha. Am J Epidemiol 164: 984-989. doi:10.1093/aje/kwj294. PubMed: 16931544.
39. Niwa Y, Ito H, Matsuo K, Hirose K, Ito N et al. (2007) Lymphotoxin-alpha polymorphisms and the risk of endometrial cancer in Japanese subjects. Gynecol Oncol 104: 586-590. doi:10.1016/j.ygyno.2006.09.007. PubMed: 17045328.
40. Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM et al. (2007) Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 28: 704-712. PubMed: 17056605.
41. Purdue MP, Sakoda LC, Graubard BI, Welch R, Chanock SJ et al. (2007) A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors. Cancer Epidemiol Biomarkers Prev 16: 77-83. doi:10.1158/1055-9965.EPI-06-0573. PubMed: 17220333.
42. García-González MA, Lanas A, Quintero E, Nicolás D, Parra-Blanco A et al. (2007) Gastric cancer susceptibility is not linked to pro-and antiinflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol 102: 1878-1892. doi:10.1111/j.1572-0241.2007.01423.x. PubMed: 17640324.
43. Ennas MG, Moore PS, Zucca M, Angelucci E, Cabras MG et al. (2008) Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol 26: 98-103. doi:10.1002/hon.843. PubMed: 18271063.
44. Jacobs EJ, Hsing AW, Bain EB, Stevens VL, Wang Y et al. (2008) Polymorphisms in angiogenesis-related genes and prostate cancer. Cancer Epidemiol Biomarkers Prev 17: 972-977. doi:10.1158/1055-9965.EPI-07-2787. PubMed: 18398039.
45. Crusius JB, Canzian F, Capellá G, Peña AS, Pera G et al. (2008) Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 19: 1894-1902. doi:10.1093/annonc/mdn400. PubMed: 18628242.
46. Mahajan R, El-Omar EM, Lissowska J, Grillo P, Rabkin CS et al. (2008) Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Jpn J Clin Oncol 38: 626-633. doi:10.1093/jjco/ hyn075. PubMed: 18687755.
47. Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM et al. (2008) Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 17: 3161-3169. doi:10.1158/1055-9965.EPI-08-0536. PubMed: 18990758.
48. Castro FA, Haimila K, Sareneva I, Schmitt M, Lorenzo J et al. (2009) Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population - a candidate gene approach. Int J Cancer 125: 1851-1858. doi:10.1002/ijc.24529. PubMed: 19585495.
49. García-González MA, Aísa MA, Strunk M, Benito R, Piazuelo E et al. (2009) Relevance of IL-1 and TNF gene polymorphisms on interleukin-1beta and tumor necrosis factor-alpha gastric mucosal production. Hum Immunol 70: 935-945. doi:10.1016/j.humimm.2009.07.024. PubMed: 19664671.
50. Abbas S, Beckmann L, Chang-Claude J, Hein R, Kropp S et al. (2010) Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Res Treat 120: 727-736. doi:10.1007/s10549-009-0489-8. PubMed: 19672706.
51. Madeleine MM, Johnson LG, Malkki M, Resler AJ, Petersdorf EW et al. (2011) Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer. Breast Cancer Res Treat 129: 887-899. doi:10.1007/s10549-011-1520-4. PubMed: 21523452.
52. Abbas S, Beckmann L, Chang-Claude J, Hein R, Kropp S et al. (2010) Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Res Treat 120: 727-736. doi:10.1007/s10549-009-0489-8. PubMed: 19672706.
53. Excoffier L, Lischer HE (2010) Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 10: 564-567. doi:10.1111/j.1755-0998.2010.02847.x. PubMed: 21565059.
54. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA 283: 2008-2012.
55. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. doi:10.1136/bmj.327.7414.557. PubMed: 12958120.
56. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826. doi:10.7326/0003-4819-127-9- 199711010-00008. PubMed: 9382404.
57. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2. PubMed: 3802833.
58. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558. doi:10.1002/sim.1186. PubMed: 12111919.
59. Seagroatt V, Stratton I (1998) Bias in meta-analysis detected by a simple, graphical test. Test had 10% false positive rate. BMJ 316: 470; author reply: 471.
60. Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P et al. (2007) The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 120(Suppl 12): 1-39. doi:10.1002/ijc.22719. PubMed: 17405121.
61. Clouston D, Bolton D (2012) In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 2: intraductal carcinoma and ductal adenocarcinoma of prostate. BJU Int 110(Suppl 4): 22-24. doi:10.1111/j.1464-410X.2012.11612.x. PubMed: 23194119.
62. Shih CM, Lee YL, Chiou HL, Chen W, Chang GC et al. (2006) Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer 52: 15-20. doi:10.1016/j.lungcan.2005.11.011. PubMed: 16476505.
63. Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M et al. (2007) Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 110: 4455-4463. doi:10.1182/blood-2007-05-088682. PubMed: 17827388.
64. Liu Y, Sheng H, Lu L, Wu Z, Chen Q et al. (2011) Haplotype-based association of four lymphotoxin-alpha gene polymorphisms with the risk of coronary artery disease in Han Chinese. Tohoku J Exp Med 224: 119-125. doi:10.1620/tjem.224.119. PubMed: 21628868.
65. Clarke R, Xu P, Bennett D, Lewington S, Zondervan K et al. (2006) Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet 2: e107. doi:10.1371/journal.pgen.0020107. PubMed: 16839190.
66. Weinstein IB (1988) The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment - twenty-seventh G.H.A. Clowes memorial award lecture. Cancer Res 48: 4135-4143. PubMed: 3292040.